Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...

A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...

Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, ...

By December 2023, 12.3% of all glucose-lowering medication dispensations were tirzepatide among adults with T2DM ...

A mum who tried "every diet under the sun" lost 11 stone using a Mounjaro weight loss jab - after deciding she "wanted to ...

A mother who had tried "every diet under the sun" managed to shed an impressive 11 stone using a Mounjaro weight loss jab, ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...